Interestingly, an imbalance of the lymphocyte subpopulations, characterized by reduced counts of CD4+ and CD8+ T cells and an increase of natural-killer lymphocytes has been implicated as an early marker of mortality in inpatients with COVID-19 (Cantenys-Molina et al., 2020). This evidence concerns the gene CD8A and COVID-19.